Dimensional Fund Advisors LP boosted its position in Becton Dickinson and Co. (NYSE:BDX) by 9.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 395,124 shares of the company’s stock after buying an additional 34,524 shares during the period. Dimensional Fund Advisors LP owned 0.19% of Becton Dickinson and worth $67,006,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently added to or reduced their stakes in the company. Hartford Investment Management Co. increased its position in Becton Dickinson and by 0.9% in the second quarter. Hartford Investment Management Co. now owns 60,471 shares of the company’s stock worth $10,255,000 after buying an additional 563 shares during the period. Cullen Frost Bankers Inc. increased its position in Becton Dickinson and by 0.4% in the second quarter. Cullen Frost Bankers Inc. now owns 84,551 shares of the company’s stock worth $14,339,000 after buying an additional 356 shares during the period. Confluence Investment Management LLC increased its position in Becton Dickinson and by 4.2% in the second quarter. Confluence Investment Management LLC now owns 67,819 shares of the company’s stock worth $11,501,000 after buying an additional 2,715 shares during the period. Strs Ohio increased its position in Becton Dickinson and by 1.0% in the second quarter. Strs Ohio now owns 134,290 shares of the company’s stock worth $22,774,000 after buying an additional 1,379 shares during the period. Finally, Trust Co. of Vermont increased its position in Becton Dickinson and by 1.7% in the second quarter. Trust Co. of Vermont now owns 37,729 shares of the company’s stock worth $6,398,000 after buying an additional 631 shares during the period. Institutional investors own 81.96% of the company’s stock.
Shares of Becton Dickinson and Co. (NYSE:BDX) traded up 0.93% on Friday, hitting $178.08. The stock had a trading volume of 221,075 shares. The firm’s 50-day moving average is $175.78 and its 200 day moving average is $167.69. The stock has a market cap of $37.92 billion, a P/E ratio of 33.98 and a beta of 0.97. Becton Dickinson and Co. has a 1-year low of $129.50 and a 1-year high of $181.76.
Becton Dickinson and (NYSE:BDX) last announced its quarterly earnings data on Thursday, August 4th. The company reported $2.35 EPS for the quarter, beating the Zacks’ consensus estimate of $2.21 by $0.14. The firm had revenue of $3.20 billion for the quarter, compared to analyst estimates of $3.21 billion. Becton Dickinson and had a return on equity of 24.26% and a net margin of 9.24%. The business’s quarterly revenue was up 2.5% compared to the same quarter last year. During the same period last year, the company earned $2.05 EPS. Equities analysts forecast that Becton Dickinson and Co. will post $8.56 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, September 30th. Stockholders of record on Friday, September 9th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date of this dividend is Wednesday, September 7th. Becton Dickinson and’s dividend payout ratio (DPR) is currently 50.19%.
A number of equities analysts have recently commented on BDX shares. Citigroup Inc. downgraded Becton Dickinson and from a “neutral” rating to a “sell” rating and cut their price objective for the stock from $167.00 to $165.00 in a report on Friday, September 23rd. Zacks Investment Research downgraded Becton Dickinson and from a “buy” rating to a “hold” rating in a report on Wednesday, July 13th. Jefferies Group reiterated a “buy” rating on shares of Becton Dickinson and in a report on Friday, August 5th. Bank of America Corp. reiterated a “buy” rating on shares of Becton Dickinson and in a report on Tuesday, July 12th. Finally, Cowen and Company reiterated an “outperform” rating and set a $185.00 target price on shares of Becton Dickinson and in a report on Tuesday, August 16th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. Becton Dickinson and currently has an average rating of “Buy” and an average target price of $170.82.
In other news, insider Gary M. Cohen sold 29,367 shares of the stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $176.81, for a total value of $5,192,379.27. Following the transaction, the insider now owns 125,870 shares of the company’s stock, valued at approximately $22,255,074.70. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Linda M. Tharby sold 11,704 shares of the stock in a transaction on Tuesday, September 6th. The shares were sold at an average price of $177.27, for a total value of $2,074,768.08. Following the completion of the transaction, the insider now directly owns 22,146 shares in the company, valued at approximately $3,925,821.42. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.
Becton Dickinson and Company Profile
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Receive News & Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related companies with MarketBeat.com's FREE daily email newsletter.